I just want to update you guys on avodart being released for hairloss. I recently contacted Glaxo and this is what they said.
Dear Mr. Brian Liles:
Thank you for contacting GlaxoSmithKline about AVODARTŪ (dutasteride).
GSK will not be pursuing further studies on the use of dutasteride for AGA (alopecia - male pattern hair loss). This decision is based on market research analyses and not for any safety or efficacy reasons.
A copy of the prescribing information for this product is available at http://us.gsk.com/products/assets/us_avodart.pdf for review and discussion with an appropriate healthcare provider.
We appreciate the opportunity to serve you. If you have further questions concerning GlaxoSmithKline or our products, please contact our Response Center at 1-888-825-5249 during our normal business hours, Monday through Friday 8:00 A.M. to 6:00 P.M. (Eastern Time).
This is a send only email address. Please do not reply to this email.
Response Center Representative